Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/a-1164-4161 http://scihub22266oqcxt.onion/10.1055/a-1164-4161 32731280!ä!32731280       Dtsch+Med+Wochenschr 2020 ; 145 (15): 1063-1067 Nephropedia Template TP {{tp|p=32731280|t=2020. COVID-19 aus Sicht der Kardiologie |pdf=|usr=}}{{32731280}} gab.com Text COVID-19 aus Sicht der Kardiologie JO: Dtsch Med Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=32731280 #FOAvip The SARS-CoV-2 pandemic has rapidly spread around the world and has led to a substantial morbidity and mortality in many countries. Although Corona Virus Disease 19 (COVID-19) is primarily a respiratory tract infection, there is growing evidence that other organs including the cardiovascular system are affected by COVID-19. In this review, we summarize the association of myocardial injury with in-hospital mortality of COVID-19 patients. Furthermore, we discuss potential mechanisms of myocardial injury including myocarditis and vascular thrombosis. Last, we review the current evidence on drugs which have been evaluated or are currently tested for the treatment of COVID-19 patients. Twit Text FOAVip COVID-19 aus Sicht der Kardiologie ????Dtsch Med Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=32731280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32731280 #FOAvip English Wikipedia <ref>{{Cite pmid|32731280}}</ref> COVID-19 aus Sicht der Kardiologie #MMPMID32731280 Weckbach LT; Kellnar A; Stremmel C; Stark K; Kaab S Dtsch Med Wochenschr 2020[Jul]; 145 (15): 1063-1067 PMID32731280show ga The SARS-CoV-2 pandemic has rapidly spread around the world and has led to a substantial morbidity and mortality in many countries. Although Corona Virus Disease 19 (COVID-19) is primarily a respiratory tract infection, there is growing evidence that other organs including the cardiovascular system are affected by COVID-19. In this review, we summarize the association of myocardial injury with in-hospital mortality of COVID-19 patients. Furthermore, we discuss potential mechanisms of myocardial injury including myocarditis and vascular thrombosis. Last, we review the current evidence on drugs which have been evaluated or are currently tested for the treatment of COVID-19 patients. |*Betacoronavirus[MESH] |Adenosine Monophosphate/adverse effects/analogs & derivatives/therapeutic use[MESH] |Alanine/adverse effects/analogs & derivatives/therapeutic use[MESH] |Antiviral Agents/adverse effects/therapeutic use[MESH] |Arteritis[MESH] |COVID-19[MESH] |Cardiovascular Diseases/*virology[MESH] |Coronavirus Infections/*complications/drug therapy/physiopathology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/drug therapy/physiopathology[MESH] |SARS-CoV-2[MESH]COVID-19 aus Sicht der Kardiologie (epmc).pdf DeepDyve Pubget Overpricing